Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD)
Status:
Terminated
Trial end date:
2018-04-17
Target enrollment:
Participant gender:
Summary
Cadazolid has demonstrated activity against a bacteria named Clostridium difficile in animal
studies. The results of a first study conducted in adult patients have suggested efficacy of
the new antibiotic, cadazolid, in the treatment of diarrhea caused by this bacteria. This is
the first study of cadazolid in children. The overall purpose of this study is to provide
reassurance on the safety and efficacy of cadazolid in children suffering from infection due
to Clostridium difficile.